Correlation Between Uniqure NV and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Uniqure NV and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uniqure NV and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Uniqure NV and Akero Therapeutics, you can compare the effects of market volatilities on Uniqure NV and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uniqure NV with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uniqure NV and Akero Therapeutics.
Diversification Opportunities for Uniqure NV and Akero Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Uniqure and Akero is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Uniqure NV and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Uniqure NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uniqure NV are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Uniqure NV i.e., Uniqure NV and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Uniqure NV and Akero Therapeutics
Given the investment horizon of 90 days Uniqure NV is expected to under-perform the Akero Therapeutics. In addition to that, Uniqure NV is 1.4 times more volatile than Akero Therapeutics. It trades about -0.28 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about -0.21 per unit of volatility. If you would invest 4,486 in Akero Therapeutics on January 12, 2025 and sell it today you would lose (919.00) from holding Akero Therapeutics or give up 20.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Uniqure NV vs. Akero Therapeutics
Performance |
| Timeline |
| Uniqure NV |
| Akero Therapeutics |
Uniqure NV and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Uniqure NV and Akero Therapeutics
The main advantage of trading using opposite Uniqure NV and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uniqure NV position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Uniqure NV vs. Rocket Pharmaceuticals | Uniqure NV vs. Rhythm Pharmaceuticals | Uniqure NV vs. Solid Biosciences LLC | Uniqure NV vs. MeiraGTx Holdings PLC |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |